Avenue Therapeutics Inc (ATXI) has released an update.
Avenue Therapeutics, Inc. shareholders have approved a significant expansion of the company’s stock capacity, raising the authorized common stock from 75 million to 200 million shares. This strategic move, finalized with a Certificate of Amendment in Delaware, aims to bolster the company’s financial flexibility and potential for growth, marking a pivotal moment for current and prospective investors.
For further insights into ATXI stock, check out TipRanks’ Stock Analysis page.
